LINEAS DE INVESTIGACIÓN

Diabetes.


PUBLICACIONES RELEVANTES DE LOS ULTIMOS 5 AÑOS

Hernández-Jiménez S, García-Ulloa AC, Bello-Chavolla OY, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D, for the Group of Study CAIPaDi. Long-term effectiveness of a type 2 Diabetes comprehensive care program. The CAIPaDi model. Diabetes Research and Clinical Practice (2019), doi: https://doi.org/10.1016/j.diabres.2019.04.009



Villegas-Narváez A, Urbina-Arronte Luz, García-Ulloa AC, Hernández-Jiménez S, por el Grupo de Trabajo CAIPaDi. Evaluación de la actividad física para alcanzar un estilo de vida activo en los profesionales de la salud: estudio piloto. Rev ALAD. 2018; 8:145-51



López Reyes AS, Patiño-Rivera E, García-Ulloa AC, Hernández-Jiménez S, for the Group of Study CAIPaDi. Periodontal status at two years of follow-up in patients with Newly Diagnosis of type 2 Diabetes Mellitus. International Journal of Clinical Endocrinology and Metabolism 2019; 1-5. DOI: http://dx.doi.org/10.17352/ijcem



Jiménez-Corona A, Nelson RG, Jiménez-Corona ME, Franks PW, Aguilar-Salinas CA, Graue-Hernández EO, Hernández-Jiménez S, Hernández-Avila M. Disparities in prediabetes and type 2 diabetes prevalence between indigenous and nonindigenous populations from Southeastern Mexico: The Comitan Study. J Clin Transl Endocrinol. 2019; 16:100191. Published 2019 Apr 20. doi: 10.1016/j.jcte.2019.100191



García-Ulloa AC, Landa-Anell V, Melgarejo-Hernández M, Villegas-Narváez A, Urbina-Arronte LE, Hernández-Jiménez S, for the CAIPaDi Study Group. Assessment of a multidisciplinary intervention in patients with BMI ≥35Kg/m2 and recently diagnosed type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism Vol 104, Issue 7, July 2019: 2994-3002. DOI: 10.1210/jc.2018-01148



Mesa-Pérez JA, Odriozola A, Antonucci R, Campillo N, Márquez G, Costa Gil J, Ziegler D, Hernández-Jiménez S, Faget O, Davidson J, Ibrahim A. Guías ALAD basadas en evidencias para el diagnóstico y el tratamiento de la polineuropatía sensitivomotora diabética 2019 (Grupo NeuroALAD). Rev ALAD. 2019;9: 1-27



Landa-Anell MV, Melgarejo-Hernández MA, García-Ulloa AC, Del Razo-Olvera FM, Velázquez-Jurado HR, Hernández-Jiménez S, for the Group of Study CAIPaDi. Barriers to adherence to a nutritional plan and strategies to overcome them in patients with type 2 diabetes mellitus; results after two years of follow-up [published online ahead of print, 2019 Aug 3]. Endocrinol Diabetes Nutr. 2019; S2530-0164(19)30150-8. doi: 10.1016/j.endinu.2019.05.007



van Olmen J, Erwin E, García-Ulloa AC, Meessen B, Miranda J, Bobrow K, lwelunmore J, Obiezu-Umeh Ch, Harding C, Kumar P, González C, Hernández-Jiménez S, Yeates K. Implementation barriers for mHealth for non-communicable diseases prevention and management in low- and middle-income countries: a scoping review and field-based views from implementers [version 1; peer review: awaiting peer review]. Wellcome Open Res 2020, 5:7 (https://doi.org/10.12688/wellcomeopenres.15581.1)



Nano J, Carinci F, Okunade O, Whittaker S, Walbaum M, Barnard- Kelly K, Barthelmes D, Benson T, Calderon-Margalit R, Dennaoui J, Fraser S, Haig R, Hernández-Jimenéz S, Levitt N, Mbanya JC, Naqvi S, Peters AL, Peyrot M, Prabhaharan M, Pumerantz A, Raposo J, Santana M, Schmitt A, Skovlund SE, García-Ulloa AC, Wee HL, Zaletel J, Massi-Benedetti M; on behalf of the Diabetes Working Group of the International Consortium for Health Outcomes Measurement (ICHOM). A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med. 2020 Mar 2. doi: 10.1111/dme.14286. [Epub ahead of print]



Graue-Hernandez E, Rivera-De-La-Parra D, Hernandez-Jimenez S, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D, Jimenez-Corona A. Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes. BMJ Open Ophthalmology 2020;5: e000304. doi:10.1136/ bmjophth-2019-000304



Antonio-Villa NE, Palma-Moreno BG, Rodríguez-Dávila FM, Gómez-Pérez FJ, Aguilar-Salinas CA, Hernández-Jiménez S, García-Ulloa AC, Almeda-Valdes P. Use of an electronic integral monitoring system for patients with diabetes to identify factors associated with an adequate glycemic goal and to measure quality of care. Primary Care Diabetes 2020. doi.org/10.1016/j.pcd.2020.07.009



García-Ulloa AC, Almeda-Valdes P, Aguilar-Salinas CA, Hernández-Jiménez S, Group of Study CAIPaDi. Development and Validation of a Software Linked to an Internet Portal That Facilitates the Medical Treatment and Empowerment of Patients with Type 2 Diabetes, Interaction with Medical Personnel, and the Generation of a Real-Time Registry. Journal of Diabetes Science and Technology 2020; Aug:1932296820949941. doi: 10.1177/1932296820949941



Urbina-Arronte L, Vergara JJ, Villegas-Narváez A, García-Ulloa AC, Hernández-Jiménez S, for the Group of Study CAIPaDi. Evaluation of Heart Rate Recovery in Patients with Diabetes Mellitus Type 2 and Elevated Urine Albumin/Creatinine Ratio After an Individualized Exercise Program. Curre Res Diabetes & Obes J 2020; 13(4): 555870. DOI: 10.19080/CRDOJ.2020.13.555870.



Almeda-Valdés P, Hernández-Jiménez S, Gómez-Pérez FJ, García-Ulloa AC, Campuzano-Rodríguez R, Madero-Fernández MA, De la Garza-Hernández NE, Cota-Aguilar JB, Arellano-Montaño S, Lavalle-González F. Recomendaciones para el abordaje y tratamiento de la intolerancia a la glucosa. Rev Mex Endocrinol Metab Nutr. 2020; 7:202-11. DOI: 10.24875/RME.20001965



Ruiz-Cervantes GM, García-Ulloa AC, Palacios-Vargas A, Lechuga-Fonseca C, Sierra-Esquivel A, Velasco-Pérez ML, Hernández-Jiménez S, For the Group of Study CAIPaDi. Prevalence of Misconceptions about Diabetes and their Association with Metabolic and Psychological Variables. Diabetes Obes Int J 2021; 6(1): DOI: 10.23880/doij-16000238



Almeda-Valdés P, Antonio-Villa NE, Rodríguez-Dávila FM, Palma-Moreno G, Gómez-Pérez FJ, Aguilar-Salinas CA, García-Ulloa AC, Hernández-Jiménez S. Comparison of two electronic systems for obtaining diabetes care indicators in clinical practice. Clinical Diabetes 2021; cd200069. doi.org/10.2337/cd20-0069



Hernández-Jiménez S, García-Ulloa AC, Almeda-Valdés P, Díaz-Pineda M, Lara-Sánchez C, Rodríguez-Dávila F, Gómez-Sámano MA, Antonio-Villa NE, Galindo-Fraga A, Hernández-Gissoul T, Gulías-Herrero A, Aguilar-Salinas CA, Gómez-Pérez FJ, Kershenobich-Stalnikowitz D. Comparison of Clinical Characteristics and Outcomes between Outpatients and Hospitalized Patients with Diabetes and COVID-19. Diabetes Obes Int J 2021; 6(1): DOI: 10.23880/doij-1600024



Hernández-Jiménez S, García-Ulloa AC, Aguilar-Salinas CA, González-Flores E, Zúñiga-González S, Pérez-Sánchez P, Romero-Zazueta A, Vidrio-Velázquez M, Gómez-Pérez FJ, Kershenobich-Stalnikowitz D. Recomendaciones para el abordaje integral del paciente con diabetes tipo 2. Rev Mex Endocrinol Metab Nutr 2021; 8: 43-51 doi: 10.24875/RME.20001962



García-Ulloa AC, Lechuga-Fonseca C, Del Razo-Olvera FM, Aguilar-Salinas CA, Galaviz KI, Venkat-Narayan KM, Hernández-Jiménez S, on behalf of Group of Study CAIPaDi. Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus. BMJ Open Diabetes Research & Care. 2021; 9: e001891. doi:10.1136/ bmjdrc-2020-001891



García-Ulloa AC, Cárdenas-Fragoso JL, Lozano Cruz OA, Gulías-Herrero A, Hernández-Jiménez S. Recommendations for Glycemic Treatment for Patients Receiving Dexamethasone for Treatment of COVID-19. Int Jou Diab &Endocrinol 2021; IJDE-111. DOI: 10.46715/ijde2021.02.1000111